The changing face of epidemiology in the genomics era

Epidemiology

Volumn 13, Issue 4, 2002, Pages 472-480

  Millikan, Robert ^a  

^a University of North Carolina ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; ETHNOLOGY; GENE LINKAGE DISEQUILIBRIUM; GENETIC EPIDEMIOLOGY; META ANALYSIS; POPULATION GENETICS; PRIORITY JOURNAL; PUBLIC HEALTH; RACE;

CONFOUNDING FACTORS (EPIDEMIOLOGY); EPIDEMIOLOGY; GENOMICS; HUMANS; LINKAGE DISEQUILIBRIUM; RESEARCH DESIGN;

EID: 0036283719     PISSN: 10443983     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001648-200207000-00017     Document Type: Article

References (120)

1. The sequence of the human genome
2. Initial sequencing and analysis of the human genome
3. Contemplating the end of the beginning
4. Genomics approaches to improving drug treatments
5. Shattuck lecture: Medical and societal consequences of the human genome project
6. Interface of genetics and epidemiology
7. Genetics and public health: A framework for the integration of human genetics into public health practice
8. Epidemiology and the genetic basis of disease
9. Lifelines
10. The dark side of the genome
11. Preface
12. How many diseases does it take to make a gene with SNPs?
13. An information-intensive approach to the molecular pharmacology of cancer
14. Epidemiology faces its limits
15. Fishing expeditions
16. Facing the challenge of gene-environment interaction: The two-by-four table and beyond
17. Searching for genetic determinants in the new millennium
18. The future of genetic case-control studies
19. Recent advances in the polymerase chain reaction
20. Pitfalls in N-acetyltransferase genotyping
21. PCR bias toward the wild-type k-ras and P53 sequences: Implications for PCR detection of mutations and cancer diagnosis
22. Laboratory methods for the determination of genetic polymorphisms in humans
23. Biased tests of association: Comparisons of allele frequencies when departing from Hardy-Weinberg proportions
24. Samplings SNPs
25. Data standards on the horizon
26. Screening a large reference sample to identify very low frequency sequence variants: Comparisons between two genes
27. Progress for the "Mouse Gene Encyclopedia"
28. The effect that genotyping errors have on the robustness of common linkage-disequilibrium measures
29. A transmission/disequilibrium test that allows for genotyping errors in the analysis of single-nucleotide polymorphism data
30. Misclassification in case-control studies of gene-environment interactions: Assessment of bias and sample size
31. Basic methods for sensitivity analysis of biases
32. Applications of the case-control method in genetic epidemiology
33. N-acetyltransferase genetics and their role in predisposition to aromatic and heterocyclic amine-induced carcinogenesis
34. Linkage disequilibrium in the human genome
35. Model-free analysis and permutation tests for allelic associations
36. Bayesian haplotype inference for multiple linked single-nucleotide polymorphisms
37. The end of the beginning
38. Chemoprotective glucosinolates and isothiocyanates of broccoli sprouts: Metabolism and excretion in humans
39. Glutathione transferase null genotype, broccoli, and lower prevalence of colorectal adenomas
40. Dietary isothiocyanates as confounding factors in the molecular epidemiology of colon cancer
41. Genetic and epigenetic aspects of DNA methylation on genome expression, evolution, mutation and carcinogenesis
42. A computational analysis of whole-genome expression data reveals chromosomal domains of gene expression
43. Effects of occupation, lifestyle and genetic polymorphisms of CYPIA1, CYP2E1, GSTM1 and GSTT1 on urinary 1-hydroxypyrene and 2-napthol concentrations
44. Single nucleotide polymorphisms, metabolic activation and environmental carcinogenesis: Why molecular epidemiologists should think about enzyme expression
45. On the use of case series to identify disease risk factors
46. Non-hierarchical logistic models and case-only designs for assessing susceptibility in population-based case-control studies
47. Sample size requirements in case-only designs to detect gene-environment interaction
48. Case-only design to measure gene-gene interaction
49. Nontraditional epidemiologic approaches in the analysis of gene-environment interaction: Case-control studies with no controls!
50. Designing and analyzing case-control studies to exploit independence of genotype and exposure
51. On studying the joint effects of the joint effects of candidate genes and exposures
52. Potential misinterpretation of the case-only study to assess gene-environment interaction
53. Invariants and noninvariants in the concept of interdependent effects
54. Confidence intervals for measures of interaction
55. The TDT other family-based tests for linkage disequilibrium and association
56. Use of parents, sibs, and unrelated controls for detection of associations between genetic markers and disease
57. Choosing a retrospective design to assess joint genetic and environmental contributions to risk
58. The relative power of family-based and case-control designs for linkage disequilibrium studies of complex human diseases. I. DNA pooling
59. Population stratification in epidemiologic studies of common genetic variants and cancer: Quantification of bias
60. Response
61. Re: Population stratification in epidemiologic studies of common genetic variants and cancer: Quantification of bias
62. Genomic views of human history
63. Estimating African American admixture proportions by use of population-specific alleles
64. Detecting association in a case-control study while correcting for population stratification
65. Genomic control for association studies
66. Population structure in admixed populations: Effect of admixture dynamics on the pattern of linkage disequilibrium
67. Association mapping in structured populations
68. Population genetic structure of variable drug response
69. Are rare variants responsible for susceptibility to complex diseases?
70. Single nucleotide polymorphisms and the future of genetic epidemiology
71. Characterization of single-nucleotide polymorphisms in coding regions of human genes
72. SNPing away at complex diseases: Analysis of single-nucleotide polymorphisms around APOE in Alzheimer disease
73. Large upward bias in estimation of locus-specific effects from genomewide scans
74. Empirical Bayes adjustments for multiple results in hypothesis-generating or surveillance studies
75. Principles of multilevel modeling
76. Practical advantages of Bayesian analysis of epidemiologic data
77. The design of case-control studies: The influence of confounding and interaction effects
78. Replication validity of genetic association studies
79. Association studies of genetic polymorphisms and complex disease
80. Power and sample size calculations for case-control studies of gene-environment interactions with a polytomous exposure variable
81. Power and sample size calculations in case-control studies of gene-environment interactions: Comments on different approaches
82. Complexity and power in case-control association studies
83. Human genome epidemiologic reviews: The beginning of something HuGE
84. Genetic-environmental interactions and low-level exposure to carcinogens
85. Detecting gene-environment interactions using a case-control design
86. Genetic variation in alcohol dehydrogenase and the beneficial effect of moderate alcohol consumption on myocardial infarction
87. Strategic issues in the design and interpretation of studies on metabolic polymorphisms and Cancer
88. Genetic trees reveal disease origins
89. Molecular epidemiology: Focus on infection
90. Polymorphisms in drug-metabolizing enzymes: What is their clinical relevance and why do they exist?
91. Preamble
92. Benefits of "harmful" genes
93. The human genome project: Evolving status and emerging opportunities for disease prevention
94. Genetics and prevention effectiveness
95. Causal diagrams for epidemiologic research
96. The power of genetics to target surgical prevention
97. The integration of genomics into public health research, policy and practice in the United States
98. The role of genomics in public health and disease prevention
99. Role of population-based studies in assessing genetic cancer risk
100. Individual risk prediction and population-wide disease prevention
101. The privatization of risk
102. Will genetics revolutionize medicine?
103. Epidemiological evaluation of the use of genetics to improve the predictive value of disease risk factors
104. Cancer epidemiology in the last century and the next decade
105. Nature and nurture: Possibilities for cancer control
106. Sick individuals and sick populations
107. High-risk and population strategies of prevention: Ethical considerations
108. Epidemiology and the web of causation: Has anyone seen the spider?